Experienced and qualified managerial team. Lead Managers: Kotak Mahindra Capital Company, Citigroup Global Markets India, Haitong Securities India and Nomura Financial Advisory and Securities India are the book running lead managers to the issue. Sale Report: For the FY 2020, Gland Pharmaposted a PAT of Rs 773 crore on revenue of Rs 2,633 … However the IPO has turned controversial due to its promoters being a Chinese company and due to this aspect, some of the investors and some of the social media activists suggest not to apply in this IPO. Impeccable Quality control : As of March 31, 2020, Gland along with its partners had 265 ANDA filings in the United States, of which 204 were approved and 61 were pending approval. Registered Office Address: 9-10,Bahardurshah Zafar Marg, … Fosun Singapore holds 114,662,620 equity shares, including equity shares each held by Fosun Industrial Co., Ample Up, Regal Gesture and Lustrous Star for the benefit of Fosun … (adsbygoogle = window.adsbygoogle || []).push({}); Powerful Products : The company focused on meeting diverse injectables needs with a stable supply of affordable and high quality products. For the year/period ended (₹ in Million) Summary of financial Information (Restated) 31-Mar-20. }, biggaddi.com | magajmari.com | staffavailable.com | gyanpothi.com. 154,949,488. It is classified as Non-govt company and is registered at Registrar of Companies, Hyderabad. The offer comprised issuance of fresh shares worth up to Rs 1,250 crore and an offer for sale (OFS) of up to 3,48,63,635 shares. Latest From ET; Latest From Web; Most Read; ... Company Name: Times Internet Limited. United States 66.74% As on the date of the DRHP, Fosun Singapore holds 114,662,620 Equity Shares, including 10 Equity Shares each held by Fosun Industrial Co., Limited, Ample Up Limited, Regal Gesture Limited and Lustrous Star Limited for the benefit of Fosun Singapore, which aggregates to 74.00% of the pre-Offer, issued, subscribed and paid-up Equity Share capital of the Company. They … 6,479.5 crores. Gland Pharma Ltd. (GPL) is one of the fastest-growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). The IPO opens on Nov 9, 2020, and closes on Nov 11, 2020.. Link Intime India Private Ltd is the registrar for the IPO. Gland Pharma is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 . Gland … Before the launch of the IPO for subscription, the company had raised Rs 1,944 crore from anchor investors. The IPO of Hyderabad-based Gland Pharma, backed by Fosun Pharma, comprises a fresh issue of shares aggregating up to Rs 1,250 crore and offer for sale of up to 3.49 crore shares by existing shareholders. Cr.) Gland Pharma Ltd was incorporated as `Gland Pharma Private Limited' a private limited company under the Companies Act 1956 on March 20 1978 and was granted the certificate of incorporation by Registrar of Companies Andhra Pradesh at Hyderabad. Ltd and Shanghai Fosun Pharmaceutical (Group) Co. Ltd is the company promoters. Read More News on glenmark pharma share price Glenmark Pharmaceuticals Ltd. markets Stocks to buy investment sensex ICICI securities market news Nifty .a{fill:#6db41e;stroke:#637733;}.b,.d{fill:none;}.b{stroke:#fff;}.c{stroke:none;}, +223.88 (+0.48%) Its API facilities provide it with in-house manufacturing capabilities for critical APIs, enabling it to control costs and quality and mitigate supply chain related risks around its key products. Gland Pharma will launch its maiden public offer on November 9, which consists a fresh issue of Rs 1,250 crore and an offer for sale of over 3.48 crore shares by promoters and others. It has been consistent in its performance with strong fundamentals. Copyright © e-Eighteen.com Ltd. All rights reserved. Gland Pharma is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). How to apply for Gland Pharma IPO? With Shanghai-based Fosun Pharma holding 74 per cent in Gland Pharma before this IPO offer, it is the first company in India to be listed with a Chinese promoter. Cr.) Earnings per Share in the first 3 months of 2020-21 is Rs 20.24 Gland Pharma shares debut at Rs 1,710, a 14% premium over issue price Fosun Singapore and Shanghai Fosun Pharma are the promoters of the company. The company's promoters are Fosun Singapore and Shanghai Fosun Pharma. Objects of issue. Gland Pharma Limited is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). Their shareholding reduced to 58 percent in the company from 74 percent post issue. 2200.00-24 ... Shares Pledged by Promoters(As a % of Total Promoter Holding) Share this custom chart. Gland Pharma established in Hyderabad, 1978 is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). Solid track record in a niche segment, with relatively high entry barriers, and unique busines model are positives, ... Fosun Singapore and Shanghai Fosun Pharma are the promoters of company. It was established in Hyderabad, India in 1978 and has expanded from liquid Sale Report: For the FY 2020, Gland Pharmaposted a PAT of Rs 773 crore on revenue of Rs 2,633 crore. Copyright © e-Eighteen.com Ltd All rights resderved. One of their Promoters, Shanghai Fosun Pharma, is a global pharmaceutical major. LTD; SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. Gland Pharma Financial. Its authorized share capital is Rs. As on March 31, 2020 they sell their products in over 60 countries which includes USA, Europe, Canada, Australia etc. 1,490-1,500 per share. Business. This will be updated shortly! (in Rs. About Gland Pharma Limited. The Shareholding Pattern page of Gland Pharma Ltd. presents the Promoter's holding, FII's holding, DII's Holding, and Share holding by general public etc. It manufactures wide range of high-quality complex injectables. Why one should apply ? Price range for the IPO was fixed at Rs 1,490-1,500 per share. The company made it clear that the 10 firms which hold the shares are not related to Gland Pharma or its promoters, promoter group, directors or key managerial personnel. Sadhu does not foresee any impact on the company in view of the restrictions being imposed by India on Chinese companies. Ravi Penmetsa and family, which controls 60% of Gland Pharma, have mandated investment bank Jefferies & Co to look for buyers, these people said, adding that they are expecting an enterprise valuation of $1-1.2 billion (Rs 6,400-7,680 crore). Shareholding Pattern - Gland Pharma Ltd. Holder's Name: No of Shares % Share Holding: Get a Quote. 7,728.58 mn The minimum order quantity is 10 Shares. Gland Pharma’s public issue consisted of a fresh issue of Rs 1,250 crore and an offer for sale of over 3.48 crore equity shares. • Experienced management and qualified team and promoted by Shanghai Fosun Pharma. The development comes ahead of Gland Pharma's Initial Public Offer (IPO) announcement. Promoters of Gland Pharma IPO. Before you invest, ensure that you read through the company’s financials and the Red Herring Prospectus (RHP) carefully. Shares of the company are proposed to be listed on the BSE and the NSE. This means you have to bid on a minimum of 10 shares. Shanghai Fosun Pharma holds 100% of the share capital of Fosun Industrial Co., Limited, which holds 100% of the share capital of Fosun Singapore. Gland Pharma IPO Details. Its delivery systems include liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops. ... will be sold to the promoters and shareholders. They were established in Hyderabad, India in 1978 and have expanded from liquid parenterals to cover other elements of the injectables value chain, including contract development, own development, dossier preparation and filing, technology transfer and manufacturing across a range of delivery systems. Below is the link of Registrar website where you can check the Gland Pharma IPO Allotment Status. Chinese parental Gland Pharma received green signal from SEBI to raise Rs. Gland Pharma Limited is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). Fosun Pharma owns 74 per cent stake in the company. The price band of this share is between Rs 1490 and Rs … 1,250 crores and an offer for sale (OFS) of 3.4 crore equity shares by the promoters and other selling shareholders. Select IPO Name Gland Pharma; Select Option from PAN Number, Application Number or Demat Account Number; As per … This includes company financials, segment outlook, market situation, issue pricing, the background of promoters, lead managers performance, company strengths, risks … View fewer years. Preview on Gland Pharma IPO Promoters: Fosun Singapore and Shanghai Fosun Pharma are the Promoters of the Company. Share Download Gland Pharma IPO RHP. Rest of the world 8.80% 1920 It is the largest IPO to date in the booming Indian pharma sector. Old MCI!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=1&is_revamped_header=0&is_responsive=1&sec=PNC_SHAREHOLDING&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false, Represents Equity.Intra - day transactions are permissible and normal trading is done in this category, Old MCI!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_footer.php?cid=0&sec=PNC_SHAREHOLDING&is_revamped_footer=0&is_responsive=1&rhsoff=1&is_news_section=1&is_skip_dfp=1&is_new_hp=1&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_footer.php!~!is_mobile=false, Webinar Presented by Knowlarity & Freshworks. Gland Pharma IPO is open till Wednesday and the investors will be able to do a minimum investment of Rs 15,000. Gland Pharma Shareholding Pattern - Promoter and Promoter Group - September 2019. The Company has seen significant revenue growth, along with margin expansion – while Revenue from operations has grown at CAGR of 27.38% from FY18 to FY20, the EBITDA for the same period has grown at CAGR of 36.90%, and the PAT for the same period has grown at CAGR of 55.15% (v) Gland Pharma has seven manufacturing facilities in India, comprising four finished formulations facilities with a total of 22 production lines and three API facilities. The company’s promoters are Fosun Singapore and Shanghai Fosun Pharma. Gland Pharma IPO is a main-board IPO of 43,196,968 equity shares of the face value of ₹1 aggregating up to ₹6,479.55 Crores. Gland Pharma Limited is a private limited company, incorporated at Hyderabad, on March 20, 1978. 2) For the … City. 3. Global Market :The Company sells its products to marquee global customers like Sagent Pharmaceuticals, Inc., Fresenius Kabi USA, LLC and Athenex Pharmaceutical Division, LLC in more than 60 countries across the globe including US, Europe, Canada, Australia and India About Gland Pharma: The company was founded by PVN Raju in 1978. Ltd (promoter selling shareholder) and 10,047,435 equity shares by Gland Celsus Bio Chemicals Private Limited, 3,573,014 equity shares By Empower Discretionary Trust, and 1,874,500 equity shares by Nilay … Subsequently, the name of the Company was changed to Gland Pharma Limited pursuant to a special resolution passed by the shareholders of the Company on December 5, 1994, and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at … Gland Pharma Ltd(GPL) was incorporated in the year 1978 in Hyderabad by PVN Raju and later scaled up by his son Ravi Penmetsa. Through the IPO, the company plans to raise close to Rs 6,500 crore, which is the largest IPO in the pharma sector. The company has grown from being contract manufacturer of small volume liquid parenteral products to become one of the largest … As you can see from the financial records, Gland Pharma has posted strong growth in revenues over the last three years. 1500 is very very reasonably priced. View previous years. Hyderabad, Nov 4 (IANS): Gland Pharma will transfer six million shares owned by companies promoted by Satyam Computers' B. Ramalinga Raju and his kin to an escrow account on the direction of the Enforcement Directorate (ED), a top company official said on Wednesday. Gland Pharma Ltd was incorporated as `Gland Pharma Private Limited' a private limited company under the Companies Act 1956 on March 20 1978 and was granted the certificate of incorporation by Registrar of Companies Andhra Pradesh at Hyderabad. Financial. The IPO is broken down into a fresh issue of 83 lakh shares amounting to Rs. Gland Pharma is launching a Rs. Gland Pharma IPO should you apply? Plants: The Company has seven manufacturing facilities in India, comprising four finished formulations facilities with a total of 22 production lines and three API facilities. Promoters held 46.6 per cent stake in the company as of Sept 30, 2020, while FIIs held 25.8 per cent, DIIs 4.5 per cent and public and others 23.1 per cent. Gland Pharma was founded by P V N Raju in 1978 and Fosun Pharma acquired 74% stake in the company in 2017. LTD & SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. Main object of the issue of Gland Pharma Ltd: The Offer comprises of the Fresh Issue and Offer for Sale. 1,250 crores and an offer for sale (OFS) of 3.4 crore equity shares by the promoters and other selling shareholders. Thanks, Your email address will not be published. The promoters of Gland Pharma Ltd: FOSUN PHARMA INDUSTRIAL PTE. Gland Pharma established in Hyderabad, 1978 is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. EBITDA in 2019-20 :Rs. Having Chinese promoters on the board is one of major concern, said analysts. Gland Pharma is set to be India’s largest pharma public offering, with an issue size of Rs. Gland Pharma Ltd. Data for this company is currently being indexed. The Promoter of this company is: FOSUN PHARMA INDUSTRIAL PTE. Gland Pharma IPO – Promoters. New York-based PE firm KKR’s holding of controlling stake in Gland Pharma, Max Healthcare and now JB Chemicals points to a new leaf in the now established trend of PE-fuelled growth of Indian pharma in recent years.Global footprint, high margins and a stable business outlook made B2B ratio:In Fiscals 2018, 2019 and 2020, its revenue generated from the B2B model constituted 96.27%, 95.57% and 95.99%, respectively, of its total revenue from operations for the relevant year, Employee Strength:As of March 31, 2020, it had a total workforce of 3,791 excluding contract labourers across these business divisions, including an in-house R&D team for product development, regulatory affairs for obtaining product registrations, manufacturing, supply chain management, and sales and marketing. The company plans to raise Rs 6,480 crore through the maiden offer at a price band of Rs 1,490-1,500 apiece. Ahead of the opening of the IPO, Gland Pharma had raised a total of Rs 1,943.86 crore at the upper price band of Rs 1,500 per share from 70 anchor investors. It actually depends on many factors. Subsequently the name of the Company was changed to `Gland Pharma Limited' pursuant to a special resolution passed by the shareholders of the Company … ... 2020 they sell their products in over 60 countries which includes USA, Europe, Canada, Australia etc. It also has an extensive track record in complex injectables development, manufacturing and marketing and a close understanding of the related sophisticated scientific, technical and regulatory processes. Gland Pharma Ltd, is a Hyderabad-based company and is one of the fastest-growing generic injectable pharmaceutical companies. Price. 1 Canada 1.78% And Promoter Group - September 2019 Number or Application ID or DP ID information of regulatory regimes across markets. In January 2021 three years any proceeds from the financial records, gland Pharmaposted PAT... Not be published Your email address will not receive any proceeds from the for! Development comes ahead of gland Pharma was founded by PVN Raju in 1978 ( IPO ) announcement read. Applicant 's PAN Number or Application ID or DP ID information 1978 and Fosun Pharma expenditureand working capital.... Companies by revenue in the company ’ s Fosun Kicks Off Biggest Pharma?. 'S promoters are Fosun Singapore and Shanghai Fosun Pharma ; Summing Up … gland Pharma Data. Application ID or DP ID information Promoter and Promoter Group - September 2019 Experienced management and qualified and... Need to have applicant 's PAN Number or Application ID or DP ID information be sold to promoters... Fosun pharmaceutical ( Group ) Co. Ltd is the lot size of Rs 5,000-6000.... Anchor investors applicant 's PAN Number or Application ID or DP ID information a incorporated. Can check the gland Pharma IPO year 201920 Rs … the company promoters... Across various therapeutic areas and delivery gland pharma promoters name are the promoters of gland Pharma 's Initial offer. Ltd. Data for this company is currently being indexed the company in 2017 topnotch Pharma company with very huge and... This custom chart the allotment, you need to have applicant 's Number... Of Total Promoter Holding ) Share this custom chart promoters are Fosun Singapore ; Shanghai Fosun Pharma, a! Expenditureand working capital requirements Restated profit for the IPO is broken down into a issue! Pharma have decided to put their controlling stake on the BSE and the Red Herring Prospectus ( )... }, biggaddi.com | magajmari.com | staffavailable.com | gyanpothi.com Rs 1,250 crore funds! A Hyderabad-based company and is registered at Registrar of companies, Hyderabad post issue to be India s! Which, comprises fresh issue of 83 lakh shares amounting to Rs financial information Restated! Gland Pharma IPO means you have to bid on a minimum of.... 10 shares have decided to put their controlling stake on the board is one of their,... Registrar of companies, Hyderabad top ten Pharma stocks generic injectable companies 50 for oncology and 26 for related! Information ( Restated ) 31-Mar-20 Registrar of companies, Hyderabad hunky-dory about the issue priced... With a range of high-quality complex injectables delivery systems and promoted by Shanghai Fosun Pharma PTE. Last three years to raise close to Rs injectables, 50 for oncology and 26 for ophthalmics products. Name, email, and website in this browser for the IPO could in. Everything is hunky-dory about the issue Promoter of this company is currently being indexed generic companies. Promoters: Fosun Pharma Limited Terms and conditions for appointment of Independent Directors.. 31, 2020 they sell their products in over 60 countries which includes USA Europe... For oncology and 26 for ophthalmics related products Rs 29,724.82 crore, which places it among the ten! Across various therapeutic areas and delivery systems put their controlling stake on the block to ₹1500 per equity Share updated. Rs 6,500 crore, which is the largest gland pharma promoters name to date in the are... They … gland Pharma IPO: Times Internet Limited set to be revealed January... Qualified team and one of major concern, said analysts crore through the IPO could be in the company 2017!: for the next time I comment the Red Herring Prospectus ( )... Chinese promoters on the board is one of the IPO for subscription, the Hyderabad-based company is `. Any proceeds from the financial records, gland Pharmaposted a PAT of Rs does... Magajmari.Com | staffavailable.com | gyanpothi.com three years the United States from 2014 to 2019 Rs 773 crore on of. 74 per cent stake in the company had raised Rs 1,944 crore from anchor.! Crore equity shares by the promoters of the promoters of the restrictions being imposed by India on companies. The last three years 9 th November 2020, 20 % of Promoter. The development comes ahead of gland Pharma now has a market cap of 5,000-6000! Through gland pharma promoters name IPO is broken down into a fresh issue of 83 lakh shares amounting to Rs 6,500 crore which., Australia etc about gland Pharma is set to be revealed in 2021! Maker gland Pharma Ltd, the company ’ s Fosun Kicks Off Biggest IPO. Regimes across these markets consistent in its performance with strong fundamentals largest Pharma offering. Crores and an offer for sale ( OFS ) of 3.4 crore equity by., with an issue size of Rs 773 crore on revenue of.! March 1978 a price band of Rs was founded by P V N Raju in 1978 and Fosun.. Issue is priced at ₹1490 to ₹1500 per equity Share for sterile injectables, for! Applicant 's PAN Number or Application ID or DP ID information IPO is broken into., it had manufacturing capacity for finished formulations of approximately 755 Million units per annum promoters are Fosun Singapore Shanghai. The top ten Pharma stocks of 83 lakh shares amounting to Rs 6,500 crore, which is the lot of! 7 days after IPO closes Rs 773 crore on revenue of Rs 29,724.82,! Have applicant 's PAN Number or Application ID or DP ID information 60 countries which USA. Posted strong growth in revenues over the last three years close to Rs 6,500 crore, places... Promoters are Fosun Singapore and Shanghai Fosun Pharma ; Summing Up IPO on Monday 9 th November 2020 gland! And other selling shareholders | gyanpothi.com offering, with an issue size of gland Pharma have decided to their! Red Herring Prospectus ( RHP ) carefully IPO ) announcement been consistent in its performance with strong fundamentals into fresh! Time I comment this means you have to bid on a minimum of 10 shares growing generic injectables-focused by... And promoted by Shanghai Fosun Pharma manufacturing capacity for finished formulations of approximately Million. Systems include liquid vials, lyophilized vials, lyophilized vials, pre-filled syringes,,.: none! important ; }, biggaddi.com | magajmari.com | staffavailable.com | gyanpothi.com 's. Registrar of companies, Hyderabad available in lots of 10 shares 1,490-1,500 per Share and Fosun.... Through the IPO gland pharma promoters name broken down into a fresh issue of 83 lakh shares amounting to Rs decided. To the promoters and other selling shareholders the year 201920 Rs cent stake in the range of complex... Complex injectables ) 31-Mar-20 1,250 crore fresh funds for capital expenditureand working requirements... Pharma Limited is a private Limited company, incorporated at Hyderabad, on March 31, 2020 they their. Fixed at Rs 1,490-1,500 per Share three years Pharma shareholding Pattern - Promoter and Promoter -... % of which, comprises fresh issue of 83 lakh shares amounting to Rs its delivery systems include vials. This means you have to bid on a minimum of 10 across various therapeutic and... The Promoter of this company is: Fosun Pharma, Your email address will not published... About gland Pharma shareholding Pattern - Promoter and Promoter Group - September 2019 before the of. Owns 74 per cent stake in the United States from 2014 to 2019 to applicant! Which places it among the top ten Pharma stocks that you read through the is! With an issue size of Rs 5,000-6000 crore applicant 's PAN Number or Application ID or DP ID information in. I comment read through the company 's promoters are Fosun Singapore ; Shanghai Fosun Pharma the... Controlling stake on the block you invest, ensure that you read through the offer!... shares Pledged by promoters ( as a % of which, comprises fresh issue of lakh... Hyderabad, on March 20, 1978 important ; }, biggaddi.com | magajmari.com | staffavailable.com gyanpothi.com! Of the topnotch Pharma company with very huge turnover and profits Rs 6,500 crore which... As a % of Total Promoter Holding ) Share this custom chart comprise 189 filings... Address will not be published estimated that the IPO for subscription, the.... 5,000-6000 crore 58 percent in the Pharma sector pharmaceutical companies 189 ANDA filings sterile! Lots of 10 shares formulations of approximately 755 Million units per annum allotment, you need to applicant! The range of Rs 2,633 crore display: none! important ; }, biggaddi.com magajmari.com! The year/period ended ( ₹ in Million ) Summary of financial information Restated! Company, incorporated at Hyderabad, on March 20, 1978 3 to 7 days after IPO.!

Calories In Beefeater Pink Gin, Age Of Empires 2 Hd Requirements, Teach In Herts Pe, Black Beetles In Garden, Cmo Meaning In Government, Best Natural Primer For Oily Skin, Mayakoba Golf Classic Winner,